Nevertheless, in a rat model of syngeneic prostate cancer, the present assay for VEGF-mediated angiogenesis revealed a close correlation between the anti-angiogenic effects in the tumor-free mesentery and the anti-tumor effects resulting from continuous s.c. infusion of paclitaxel (28). The gene discussed is VEGFA; the disease is prostate cancer.